Artikel Jurnal :: Kembali

Artikel Jurnal :: Kembali

The management of pulmonary fibrosis in covid-19

Clepoas M. Rumende, Erwin Susanto, Truely P. Sitorus (University of Indonesia. Faculty of Medicine, 2021)
 Abstrak
Pulmonary fibrosis due to COVID-19 is recognized as sequel of ARDS characterized by failed alveolar re-epithelization, fibroblast activation, excessive collagen deposition and other extracellular matrix components that disrupt the normal lung architecture. There are risk factor for pulmonary fibrosis namely advanced age, severe ARDS infection, mechanical ventilation due to ventilator-induced lung injury, smoking and chronic alcoholism. Diagnosis of post-COVID pulmonary fibrosis can be made by clinical symptoms and characteristic finding from lung CT scan. To date, there is no definitive treatment for post-inflammatory pulmonary fibrosis after COVID-19 infection, however some of antifibrotic therapies may be considered. Beside medical treatment, pulmonary rehabilitation program and long-term oxygen treatment should be included as part of comprehensive treatment for pulmonary fibrosis due to COVID
 Metadata
No. Panggil : 610 UI-IJIM 53:2 (2021)
Pengarang :
Pengarang/kontributor lain :
Subjek :
Penerbitan : Jakarta: University of Indonesia. Faculty of Medicine, 2021
Sumber PengataloganLibUI eng rda
ISSN01259326
Majalah/JurnalThe Indonesian Journal of Internal Medicine
VolumeVol. 53, No. 2, April 2021: Hal. 233-236
Tipe Konten text
Tipe Media unmediated
Tipe Carrier volume ; online resource
Akses Elektronik
Institusi Pemilik Universitas Indonesia
Lokasi Perpustakaan UI, Lantai 4 R. Koleksi Jurnal
  • Ketersediaan
  • Ulasan
  • Sampul
No. Panggil No. Barkod Ketersediaan
610 UI-IJIM 53:2 (2021) 08-21-79321328 TERSEDIA
Ulasan:
Tidak ada ulasan pada koleksi ini: 20513355